气溶胶、鼻内或胃肠外接种在恒河猴中诱导独特的细胞与体液免疫特征
研究比较腺病毒载体疫苗经鼻内、小气溶胶液滴(4μm)和大气溶胶液滴(10μm)接种恒河猴后的细胞与体液免疫应答。气溶胶递送诱导最高肺CD4和CD8 T细胞应答,支气管肺泡灌洗细胞中疫苗特异性水平达10-30%;鼻内递送肺T细胞应答峰值低逾10倍。全身(血液)T细胞应答仅见于4μm气溶胶和胃肠外免疫,所有途径体液应答相似。
要点
- 气溶胶递送(4或10μm液滴)诱导最高肺CD4和CD8 T细胞应答,支气管肺泡灌洗细胞中达10-30%。
- 鼻内递送免疫原性较低,肺T细胞应答峰值低逾10倍。
- 全身(血液)T细胞应答仅见于4μm气溶胶和胃肠外免疫,所有途径体液应答相似。
核心结论
- 不同呼吸道疫苗接种方式产生不同的免疫应答特征,小液滴气溶胶可能较其他呼吸道途径具有若干免疫学优势。
研究设计与样本
- 在恒河猴中比较腺病毒载体疫苗经鼻内、4μm小气溶胶液滴和10μm大气溶胶液滴接种后的免疫应答,涵盖初次免疫或加强已致敏的全身应答。
主要发现
- 气溶胶递送(4或10μm直径液滴,分别针对下或上气道)产生最高肺CD4和CD8 T细胞应答,支气管肺泡灌洗细胞中疫苗特异性水平达10-30%。
- 鼻内递送免疫原性较低,肺T细胞应答峰值低逾10倍。
- 全身(血液)T细胞应答仅见于4μm气溶胶和胃肠外免疫后,而所有递送途径诱发的体液应答相似。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Respiratory mucosa immunization is capable of eliciting both local and distal mucosal immune responses; it is a potentially powerful yet largely unused modality for vaccination against respiratory diseases. Targeting the lower versus upper airways by aerosol delivery alters the immunogenicity profile of a vaccine, although the full extent of this impact is not well characterized. We set out to define the cellular and humoral response profiles elicited by immunization via intranasal, small aerosol droplets, and large aerosol droplets. We compared responses following adenovirus-vectored vaccination by these routes in macaques, either for the generation of primary immune responses or for the boosting of previously primed systemic responses. Aerosol delivery (4 or 10μm diameter droplets, addressing lower or upper airways, respectively) generated the highest magnitude lung CD4 and CD8 T-cell responses, reaching 10-30% vaccine-specific levels in bronchoalveolar lavage cells. In contrast, intranasal delivery was less immunogenic with >10-fold lower peak lung T-cell responses. Systemic (blood) T-cell responses were only observed following 4μm aerosol (and parenteral) immunization, while all delivery routes elicited similar humoral responses. These data demonstrate distinct immune response profiles with each respiratory tract vaccination modality and suggest that small droplet aerosol offers several immunological advantages over other respiratory routes.
引用
- Bolton DL, Song K, Tomaras GD, et al. Unique cellular and humoral immunogenicity profiles generated by aerosol, intranasal, or parenteral vaccination in rhesus macaques. Vaccine. 2016. PMID: 28041780. doi:10.1016/j.vaccine.2016.12.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。